Allogene Therapeutics, Inc. (ALLO) Net income 2018–2025
Allogene Therapeutics, Inc. (ALLO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$190.9MFY2025 · since FY2018: -$211.5M → -$190.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$190.9M | +25.9% |
| FY2024 | -$257.6M | +21.3% |
| FY2023 | -$327.3M | +3.9% |
| FY2022 | -$340.4M | -87.0% |
| FY2021 | -$182.1M | +42.5% |
| FY2020 | -$316.4M | -71.4% |
| FY2019 | -$184.6M | +12.7% |
| FY2018 | -$211.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice